BOZEN, Sud-Tirol, Italy, May 7, 2012 /PRNewswire/ --
Health Robotics today announced a new indirect sales and service channel for its world leading i.v.STATION ONCO, i.v.STATION, and i.v.SOFT products with Korean-based market leader Dongbang Healthdyne. Health Robotics continues to lead the global healthcare industry and persisting on its worldwide quest to pervasively provide safe and cost-effective Intravenous Admixture Compounding Automation to hospitals all over the world.
Byung Ahn, Dongbang Healthdyne' President, stated: "Following the dramatic increase in life expectancy of the Korean population, we have recently experienced a three-fold increase of cancer patients in our country. Compounding Oncology IV preparations is rapidly becoming a large unsolved issue for Korean hospitals. Our market research shows very prosperous business projections for Health Robotics, especially for its 2nd Generation i.v.STATION ONCO, as Korean pharmacists look forward to replace with Robots this "low-level" work [legally part of their duties], and in my opinion, they are not going to accept the old technology alternatives."
Gaspar DeViedma, Health Robotics' Executive Vice President, stated: "i.v.STATION ONCO represents Health Robotics' 2nd Generation Cancer Therapy Compounding robot for syringes and I.V. Bags, introduced into the global healthcare market well before any of our competitors can even prove their fictional 20+ year old claims at any hospital in the world. Amongst the technology innovations pioneered by i.v.STATION ONCO are its: ability to handle pre-attached lines to IV Bags; small footprint [at 15% to 25% of the size/weight of other IV Robots]; faster throughput [up to 40 doses per hour instead of 20 doses per hour]; automated tamper-evident syringe capping; and finally, RFID support. Together with i.v.STATION and i.v.SOFT, we expect i.v.STATION ONCO to dominate the Korean market."
About Dongbang Healthdyne:
Dongbang Healthdyne Co., Ltd. was born from 20+ year-old Dongbang Healthcare Co., Ltd. in 2000, which is a prestigious and rapidly growing mid-sized enterprise, specializing in the healthcare business. Dongbang Healthdyne is an exclusive Korean distributor of such well-known companies as Philips Medical Systems, Hamilton Medical AB, ConMed, Hill-Rom, CareFusion, etc.
About Health Robotics:
Founded in 2006, Health Robotics is the undisputed global leading supplier of life-critical intravenous medication robots, winning 100% of all worldwide I.V. Robot's publicly announced purchases in 2010 and 2011, and providing over 250 hospital installations in 5 continents with robotics-based technology and clinical software automation solutions. Health Robotics' world-leading solutions CytoCare® and i.v.STATION® ONCO [hazardous IVs], i.v.STATION® [non-hazardous IVs], i.v.SOFT® [workflow engine for sterile compounding], OMM® [Oncology Medication Management], MEDarchiver® [life-critical clinical information system], and TPNstation™ [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' products help hospitals eliminate life-threatening drug and diluent exchange errors, decrease other medical mistakes and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and pharmacy staff. For more information, please visit: http://www.health-robotics.com
 Competitor's Announcements: MDS (now Fresenius Kabi) , RIVA/Intelligent Hospital Systems , For Health Technologies (now Baxa/Baxter) , Panasonic , Loccioni's APOTECAchemo  (under license from Health Robotics).
 Am J Hosp Pharm 46(11): 2286-93 1989
For additional information, please contact:
Claudia Flaim, Marketing Coordinator
Phone (Canada): +1-289-470-1456
Phone (Europe): +39-0471-200-372
SOURCE Health Robotics